|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 SUNY at Buffalo
2 SUNY at Buffalao
* To whom correspondence should be addressed. E-mail: canty{at}buffalo.edu.
We performed the present study to determine whether hibernating myocardium is chronically protected from ischemia. Myocardial tissue was rapidly excised from hibernating LAD regions (
WT 2.8 ± 0.2 vs. 5.4 ± 0.3 mm in remote myocardium) and high-energy phosphates were quantified by HPLC during simulated ischemia in vitro (37° C). At baseline, ATP (20.1 ± 1.0 vs. 26.7 ± 2.1 µmol/g dry weight, p<0.05), ADP (8.1 ± 0.4 vs. 10.3 ± 0.8 µmol/g, p<0.05) and total adenine nucleotides (31.2 ± 1.3 vs. 40.1 ± 2.9 µmol/g, p<0.05) were depressed vs. normal myocardium while total creatine, CP and ATP/ADP ratios were unchanged. During simulated ischemia, there was a marked attenuation of ATP depletion (5.6 ± 0.9 vs. 13.7 ± 1.7 µmol/g at 20-minutes in control, p<0.05) and mitochondrial respiration (State 3 145 ± 12.6 vs. 187 ± 11.2 ng atoms O2/mg protein/min, p< 0.05) while lactate accumulation was unaffected. These in vitro changes were accompanied by protection of the hibernating heart from acute stunning during demand-induced ischemia. Thus, despite contractile dysfunction at rest, hibernating myocardium is ischemia tolerant with reduced mitochondrial respiration and slowing of ATP depletion during simulated ischemia which may maintain myocyte viability.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |